Does Parathyroid Hormone Interact with Ropinirole Hydrochloride?
CDI records a moderate classification for Parathyroid Hormone and Ropinirole Hydrochloride. The stored summary is: Higher doses of estrogens reduce ropinirole clearance; starting or stopping HRT may require ropinirole dose adjustment. The mechanism involves reduced clearance of ropinirole by estrogens. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Reduced clearance of ropinirole by estrogens
What To Tell Your Doctor or Pharmacist
If you are taking Parathyroid Hormone and your doctor is considering prescribing Ropinirole Hydrochloride (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider